 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 04 April 2024) Immunocore Holdings plc (Nasdaq: IMCR) ( Immunocore or the...

Immunocore to present at upcoming investor conferences

Citigroup Inc. decreased its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 18.3% during the third quarter, according to the company in its most recent Form 13F filing...

Citigroup Inc. Sells 671 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

For the last three days, A.I.dvisor has detected that IMCR's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Immunocore Holdings (IMCR, $63.51) Aroon Indicator entered a Downtrend on March 22, 2024.

Immunocore Holdings (IMCR, $62.01) Aroon Indicator entered a Downtrend on March 21, 2024.

Immunocore Holdings (IMCR, $62.9) Aroon Indicator entered a Downtrend on March 20, 2024.

Immunocore Holdings (IMCR, $61.61) Aroon Indicator entered a Downtrend on March 19, 2024.

Immunocore Holdings plc (NASDAQ:IMCR  Get Free Report) saw a significant growth in short interest in the month of February. As of February 29th, there was short interest totalling 4,230,000...

Immunocore Holdings plc (NASDAQ:IMCR) Sees Large Growth in Short Interest

In trading on Tuesday, shares of Immunocore Holdings PLC (IMCR) crossed below their 200 day moving average of 59.49, changing hands as low as 59.43 per share. Immunocore Holdings PLC...

Immunocore Holdings (IMCR) Shares Cross Below 200 DMA

Immunocore Holdings (IMCR, $60.4) Aroon Indicator entered a Downtrend on March 18, 2024.

Immunocore Holdings (IMCR, $60.91) Aroon Indicator entered a Downtrend on March 15, 2024.

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Volume (M)	434,223.00
52-Wk High	$76.98
52-Wk Low	$42.21

IMCR Immunocore Holdings PLC - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals